SLNO
NASDAQ · Biotechnology
Soleno Therapeutics Inc
$31.04
-0.68 (-2.14%)
Performance
1D
—
1W
—
1M
—
3M
-34.86%
6M
-52.22%
1Y
-37.98%
YTD
-34.20%
Open$31.32
Previous Close$31.72
Day High$31.44
Day Low$30.93
52W High$90.32
52W Low$32.15
Volume—
Avg Volume1.62M
Market Cap1.71B
P/E Ratio82.09
EPS$0.16
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$44.35
Below
SMA 200
$63.31
Below
RSI (14)
47.2
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
19 analysts
Price Target
-35.7% upside
Current
$31.04
$31.04
Target
$19.95
$19.95
$16.99
$19.95 avg
$27.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 186.85M | 785.64M | 787.82M |
| Net Income | 20.50M | 73.80M | 76.85M |
| Profit Margin | 11.0% | 9.4% | 9.8% |
| EBITDA | 11.22M | 123.66M | 121.59M |
| Free Cash Flow | — | 65.88M | 73.67M |
| Rev Growth | +298.9% | +24.2% | +9.0% |
| Debt/Equity | 0.11 | 0.21 | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |